YHEC research makes strong Business Case for Antimicrobial Copper Touch Surfaces

York Health Economics Consortium, a global leader in healthcare-associated modelling, were commissioned by the International Copper Association to develop a fully-referenced cost-benefit model, to calculate the Return on Investment of installing Antimicrobial Copper.

The payback times demonstrated by the model back the findings of Professor Tom Elliott, Consultant Microbiologist at the University Hospitals Birmingham NHS Foundation Trust and leader of the UK clinical trial of Antimicrobial Copper.
At an event last year, he noted: “For the one-off cost of installing Antimicrobial Copper surfaces, you get continuous microbial contamination reduction throughout the products’ life, and these materials are durable and long-lasting.  The cost for a 20-bed medical ward was equivalent to the cost of just 1.5 infections”.

——


Return on investment? What Payback period?

Antimicrobial copper touch surfaces installed in intensive care units (ICUs) pay for themselves in less than a year, according to a cost-benefit model developed by the York Health Economics Consortium (YHEC) and commissioned by the International Copper Association. This is due to the resulting reduction in surface bioburden and hence healthcare-associated infections (HCAIs).


Read more:-



Does it really work? How? Prove it!

Sometimes, it feels like there are so many claims made of a ‘miracule cure’ or ‘wonder product’, which are later found to be woefully lacking in solid scientific testing and peer-reviewed analytical publications within mainstream journals.

Thankfully, that’s not the case with copper: don’t simply take our word for it – have a look for yourself, and if you have any questions, you can of course ask us for guidance.

More details and references via these pages:






Selly Oak Hospital ward trial

What difference did installing copper surfaces make to cleanliness within a 20 bed hospital ward?


90–100% less microbial contamination on copper items, compared to standard ones.


The first results were presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, 28th October 2008. The study found that, when tested, items made from copper had 90-100% fewer micro-organisms, compared with the same items made out of standard materials.

The results were later published here:
A.L. Casey, D. Adams, T.J. Karpanen, P.A. Lambert, B.D. Cookson, P. Nightingale, L. Miruszenko, R. Shillam, P. Christian and T.S.J. Elliott, J Hosp Infect (2009), doi:10.1016/j.jhin.2009.08.018.)

Professor Tom Elliot, Medical Director, University Hospitals Birmingham NHS Foundation Trust on the latest status of the trial:

‘The findings of a 90 to 100% killing of those organisms, even after a busy day on a medical ward with items being touched by numerous people, is remarkable. So it may well offer us another mechanism for trying to defeat the spread of [bacteria that cause] infection.’

Read more here: http://www.antimicrobialcopper.org/uk/node/12687


More case studies, from differing settings around the world, here: http://www.antimicrobialcopper.org/uk/case-studies